Pi-Medical Ltd acquired ISO 13485:2012 certification by TuV Austria Hellas
News
Inverse optimization of noise barriers
Horvath G, Kirisits C, Sachpazidis I, Drewes T, Krapf K-G, Kirisits H. "Inverse optimization of noise barriers.". In: Internoise 2013.; 2013.
A gEUD-based inverse planning technique for HDR prostate brachytherapy: Feasibility study
Giantsoudi, Baltas D, Karabis A, et al. "A gEUD-based inverse planning technique for HDR prostate brachytherapy: Feasibility study." American Association of Physicists in Medicine. 2013.
Sat, 21/01/2012
Newsletter 01/2012
Pi-Medical Ltd welcomes you to the first newsletter for 2012 and wishes everyone a creative year. Our company, within the framework of the global economic and developmental crisis, continues to develop its products in the field of oncology with constancy and responsibility.
Full text click here
Mon, 12/12/2011
EUROSTARS - CEIROS - Cutting Edge Interventional Radiooncology Optimization Software
PI-Medical Ltd received a EUROSTARS grant. The project started in November 2011 and will run for 2 years.
Tue, 23/08/2011
Software Developer/Engineer position openning
PI-Medical has an immediate opening for a Software Developer/Engineer.
Tue, 26/07/2011
BiopSee® – transperineal stereotactic navigated prostate biopsy
In the recent years, prostate cancer was the most commonly diagnosed cancer in men. Currently secure diagnosis
Mon, 06/06/2011
Optimization technology in noise barriers design
Innovative optimization technology developed by Pi-Medical used for noise barriers design.
Tue, 18/01/2011
A detailed dosimetric comparison between manual and inverse plans in HDR intracavitary/interstitial cervical cancer brachytherapy
A study on the dosimetric comparison between manual and inverse plans in HDR intracavitary/interstitial cervical cancer brachytherapy was published in the last issue of the J.
Thu, 14/10/2010
Radiobiological evaluation of the influence of dwell time modulation restriction in HIPO optimized HDR prostate brachytherapy implants
A study on the effect of dwell time restiction on the optimized prostate brachytherapy implants was published in the last issue of the J. of Contemporary Brachytherapy.
Thu, 30/09/2010
Nucletron B.V., MedCom GmbH and Pi-Medical Ltd. sign cooperation
(Veenendaal, 28 September 2010) Nucletron and MedCom GmbH & Pi-Medical Ltd, today signed a license agreement for the next generation seeds treatment planning module of Oncentra Prostate.
Fri, 03/09/2010
BiopSee® at ESTRO 2010 - A single system for total prostate cancer diagnosis & focal therapy plan
BiopSee® is going to be presented during the Industrial Exhibition at ESTRO Annual Congress: ESTRO 29 - 12th to 16th September 2010 Barcelona, Spain.
